Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › PDEs as modifiers of the IGFR pathways and methods of use

PDEs as modifiers of the IGFR pathways and methods of use

US Patent 7888047 · Granted Feb 15, 2011

Estimated economic value: $8,623,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fatty acid synthase inhibitor for use in the treatment of drug resistant cancer2019
Heterocyclic modulators of lipid synthesis and combinations thereof2019
Heterocyclic modulators of lipid synthesis2019
Methods of treating PR-positive, luminal A breast cancer with PI3K inhibitor, pi2018
Heterocyclic modulators of lipid synthesis for use against cancer and viral infe2018
Methods and compositions for modulating estrogen receptor mutants2018
Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeut2016
Methods for diagnosis, prognosis and methods of treatment2015
Mutant selectivity and combinations of a phosphoinositide 3-kinase inhibitor com2015
SCDs as modifiers of the p53 pathway and methods of use2014
SCDs as modifiers of the p53 pathway and methods of use2014
SCDs as modifiers of the p53 pathway and methods of use2014